Obesity treatment can include GLP-1 medications, non-surgical procedures such as ESG stomach tightening and short-term gastric balloons, and traditional bariatric surgery. Here’s an alarming fact: 42% ...

Amid soaring global demand for glucagon-like peptide-1 (GLP-1) medications and widespread concerns about affordability and access, the World Health Organization (WHO) released its global comprehensive ...

This week, the World Health Organization entered a new arena with its first global guideline on GLP-1 therapies for obesity ...

The World Health Organization is now recommending GLP-1 drugs as a tool to manage obesity in adults. The guidance, which says ...

Abdominal and general obesity were associated with adverse respiratory symptoms, with some independent factors identified in women, but not in men. In a study on abdominal and general obesity and ...

Please provide your email address to receive an email when new articles are posted on . Almost 75% of women with obesity reported menopausal vasomotor symptoms vs. 45% of those without obesity. Women ...

Children who respond well to pediatric obesity treatment have markedly lower morbidity and mortality risks in young adulthood, according to data published on January 21 in JAMA Pediatrics. Researchers ...

Although still in Phase I, Wave Life Sciences’ injectable RNA weight loss treatment achieved results that impressed analysts, ...

When children with obesity undergo weight-loss treatment, the effects have repercussions later in life and the risk of serious health problems and premature death is lower as they reach young ...

In addition, the obesity drug also improved knee pain in participants, Eli Lilly noted. ・Seven additional Phase 3 trials for ...

Beneficial pediatric obesity treatment response was associated with a reduced risk of obesity-related events in young adults, a nationwide prospective cohort study in Sweden showed. Compared with poor ...